Obesity Facts and Information

Takeda and Amylin to co-develop obesity drugs

Japan’s Takeda Pharmaceutical and U.S. Amylin Pharmaceuticals said on Monday they will co-develop and commercialize drugs to treat obesity, including two Amylin drugs in mid-stage trials. Takeda, Japan’s biggest drug maker and best known for its diabetes drug Actos, will pay Amylin $75 million in a one-time up-front payment under the exclusive worldwide agreement. Amylin, [...]

Continue reading...